carbuterol

Carbuterol is a beta-2 adrenergic receptor agonist and bronchodilator. It is structurally related to other beta-2 agonists such as albuterol (salbutamol) and was developed for the treatment of asthma and other respiratory conditions characterized by bronchospasm. Carbuterol acts by stimulating beta-2 adrenergic receptors in bronchial smooth muscle, leading to muscle relaxation and airway dilation, thereby improving airflow in obstructive lung diseases. However, carbuterol is not widely marketed or approved in major regions such as the United States or Europe, and there is limited clinical information available regarding its current use or approval status.